Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Proportion measure

Year Type CMS eCQM ID Measure Name
2024 EC CMS249v6 Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
2024 EC CMS314v1 HIV Viral Suppression
2023 EH CMS334v4 Cesarean Birth
2024 EH CMS334v5 Cesarean Birth
2022 EC CMS347v5 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2023 EC CMS347v6 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2024 EC CMS347v7 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2022 EC CMS349v4 HIV Screening
2023 EC CMS349v5 HIV Screening
2024 EC CMS349v6 HIV Screening
2022 EH CMS506v4 Safe Use of Opioids - Concurrent Prescribing
2023 EH CMS506v5 Safe Use of Opioids - Concurrent Prescribing
2024 EH CMS506v6 Safe Use of Opioids - Concurrent Prescribing
2022 EC CMS645v5 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2023 EC CMS645v6 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2024 EC CMS645v7 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2022 EC CMS646v2 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2023 EC CMS646v3 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2024 EC CMS646v4 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2022 EC CMS771v3 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia